SLCO2B1 and prostate cancer: Moreover, mRNA expression levels of SLCO1B1, SLCO1B3, SLCO2B1 and SLCO4C1 were found to be higher in castration-resistant prostate cancer metastases as compared to in untreated prostate cancer [63].